Evaluation of Immune-Related Response Criteria and RECIST v1.1 in Patients With Advanced Melanoma Treated With Pembrolizumab - Hodi, F S; Hwu, W J; Kefford, R (Journal of clinical oncology: official journal of the American Society of Clinical Oncology, 2016)
et al.